ARTICLE | Company News
Texas Biotech, SmithKline Beecham sales and marketing update
November 20, 2000 8:00 AM UTC
SB launched in the U.S. TXB's Argatroban synthetic thrombin inhibitor to prevent or treat thrombosis associated with heparin-induced thrombocytopenia (HIT). ...